What is Acid Reflux

(ARA) – Nearly 19 million Americans currently live with Gastroesophageal Reflux Disease (GERD), commonly known as acid reflux disease, and suffer from painful and uncomfortable symptoms such as frequent and persistent heartburn.

Hospitalized patients who receive acid-suppressive medications such as a proton-pump inhibitor have a 30 percent increased odds of developing pneumonia while in the hospital, according to a new study.

A procedure that uses heat generated by radio waves to treat Barrett’s esophagus, a condition caused by acid reflux (severe heartburn), can eliminate signs of the potentially cancer-causing disorder and reduce the risk that the disease will progress.

Galway-based medical device developer Crospon has announced a worldwide distribution deal with Dutch firm Medical Measurement Systems. MMS will distribute Crospon’s award-winning product EndoFLIP, which tests for gastroesophagel reflux disease (GERD), commonly known as acid reflux.

A procedure that uses heat generated by radio waves to treat Barrett’s esophagus, a condition caused by acid reflux (severe heartburn), can eliminate signs of the potentially cancer-causing disorder and reduce the risk that the disease will progress. Findings from the first multicenter trial of the procedure, called radiofrequency ablation, could mean patients have an alternative to surgery for treating Barrett’s esophagus.

A procedure that uses heat generated by radio waves to treat Barrett’s esophagus, a condition caused by acid reflux (severe heartburn), can eliminate signs of the potentially cancer-causing disorder and reduce the risk that the disease will progress. Findings from the first multicenter trial of the procedure, called radiofrequency ablation, could mean patients have an alternative to surgery for treating Barrett’s esophagus.

ALL students learn about acid reflux

They’re a popular choice for the pain of indigestion and heartburn, but, a new study shows more and more hospitals are giving acid reflux drugs to people who don’t need them.

Published: Wednesday, May 27, 2009 at 5:17 a.m. Last Modified: Wednesday, May 27, 2009 at 5:17 a.m. A growing number of hospital patients are routinely given drugs to prevent acid reflux.

Hospitalized patients who receive acid-suppressive medications such as a proton-pump inhibitor have a 30 percent increased odds of developing pneumonia while in the hospital, according to a study in the May 27 issue of JAMA. With the introduction of proton-pump inhibitors, used primarily in the treatment of ulcers and gastroesophageal reflux disease, the use of acid-suppressive medications has …

A new study has found that patients who take proton pump inhibitors to prevent acid reflux are at higher risk for pneumonia than those who do not.

Hospitalized patients who receive medications to control acid reflux may be more likely to develop pneumonia, report researchers in the latest issue of JAMA.

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE® (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PPI) Prilosec OTC® 40 mg (20 mg X 2), did not alter the median time it took for maximum plasma concentration of d-amphetamine to be reached in the subjects evaluated.

Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. Lansoprazole uncommonly causes chronic watery diarrhea unresponsive to conventional medication as a symptom of collagenous colitis. This association has recently been reported and is not widely known. Correct diagnosis and treatment without this knowledge is impossible.

The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses, according to a new study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions.